Alliance for Regenerative Medicine

Search ARM

We are the leading international advocacy organization championing the benefits of engineered cell therapies and genetic medicines for patients, healthcare systems, and society.

Learn More

Become a Member

Save the dates for the Cell and Gene Meeting on the Mesa!

The meeting, which runs from October 7-9, will take place at our new venue in Phoenix, AZ. Learn more!

Looking for updates on future ARM events? Sign up for our email list here!

Featured

August 2024 Sector Snapshot: The Emerging Value of Cell and Gene Therapy

This edition highlights our cell and gene therapy sector data, an update on the 2024 clinical pipeline, and ARM’s updated value framework for gene therapy and a new value framework for CAR-T cell therapy.

READ THE SNAPSHOT

Featured

Announcing ARM’s Q2 2024 Data Release

Our Q2 2024 cell and gene therapy sector data is now available! Dive into the full data on our website.

ACCESS OUR DATA

Featured

Concerned Stakeholders Issue Call to Action on the Implementation of the EU Joint Clinical Assessment for ATMPs

The new EU Joint Clinical Assessment (JCA) will become an additional barrier for patient access to transformative advanced therapies if the HTA Coordination Group does not modernize its approach to evaluating these medicines, warned 30 not-for-profit organisations, including patient groups, scientific societies, research foundations and medical institutes, in a Call to Action.

READ CALL TO ACTION

Featured

Considerations for Cell & Gene Therapy Companies Contemplating Foreign Direct Investment in Japan

This comprehensive publication outlines essential insights for companies considering investment in Japan’s burgeoning cell and gene therapy sector, covering crucial aspects such as supply chain, labor, and real estate.

READ THE WHITEPAPER

Learn About Regenerative Medicine

Regenerative medicine includes gene therapies, cell therapies, and tissue-engineered products intended to augment, repair, replace, or regenerate organs, tissues, cells, genes, and metabolic processes in the body.

Regenerative medicine aims to alter the current practice of medicine by treating the root causes of disease and disorders.

FIND OUT MORE

Discover the Alliance

ARM takes the lead on the most important issues facing the regenerative medicine and advanced therapy sector today:

Advocating for clear, predictable and harmonized regulatory and review pathways
Enabling market access and value-based reimbursement policies
Addressing industrialization and manufacturing hurdles
Conducting key stakeholder outreach, communication and education
Facilitating sustainable access to capital and identify sources of potential public funding.

Find Out More

Explore How ARM Leads the Way

As the global voice of the sector, we represent more than 400 members across 25 countries, including emerging and established biotechnology companies, academic and medical research institutions, and patient organizations.

FIND OUT MORE

Stay Connected

Newsletter Sign Up Twitter LinkedIn